fbpx Skip to main content

Member's Profile

Halozyme Therapeutics

Location
11388 Sorrento Valley Road Suite 200
San Diego,   CA
92121
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2001
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Halozyme Therapeutics
Biotech Company
Halozyme is a biopharmaceutical company developing and commercializing recombinant human enzymes for the drug delivery, palliative care, oncology, and infertility markets. The company's portfolio of products is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's EnhanzeTM Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its first partnership is with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for 13 targets. In addition, the company has received FDA approval for two products: CumulaseÃ’ and Hylenex, for use as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need.
Related News
Antibody from Sorrento Therapeutics Shows 100 Percent Inhibition of SARS-CoV-2, Halozyme Receives Massive Milestone Payment from Janssen, Genalyte & SD Blood Bank Fight COVID-19 Together
May 15, 2020
5/15/20 - Sorrento Therapeutics STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In... Read more.